<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01089920</url>
  </required_header>
  <id_info>
    <org_study_id>09.06.MET</org_study_id>
    <nct_id>NCT01089920</nct_id>
  </id_info>
  <brief_title>Dose Response Bioavailability of Coffee and Green Tea Antioxidants in Humans</brief_title>
  <official_title>Dose Response Bioavailability of Coffee and Green Tea Antioxidants in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coffee and green tea are 2 widely consumed beverages. Both contain polyphenol antioxidant
      compounds (chlorogenic acids for coffee and catechins for tea). The bioavailability of
      catechins is somewhat known and has been referenced in the literature. However,
      bioavailability data from tea infusion is non-existent, even though it reflects better how
      consumers drink this beverage. In addition, bioavailability of coffee chlorogenic acids is
      less understood and no dose response study has been reported so far in the literature. Thus,
      there is a great need to understand and reinforce our knowledge on the bioavailability of
      coffee and tea polyphenol compounds.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare plasma Area under the curve (AUC) of highest and lowest dose of coffee for chlorogenic and phenolic acid metabolites</measure>
    <time_frame>Measurements done over 24h after ingestion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare Area under the curve (AUC), Maximum plasma concentration (Cmax), Time to reach maximum plasma concentration (Tmax) and half-life (T1/2) of all three doses of coffee for chlorogenic and phenolic acid metabolites</measure>
    <time_frame>Measurements done over 12h after ingestion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare AUC, Cmax, Tmax and T1/2 of all three doses of green tea for catechin metabolites</measure>
    <time_frame>Measurements done over 12h after ingestion</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>High dose coffee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose of polyphenols from soluble coffee</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium dose coffee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medium dose of polyphenols from soluble coffee</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose coffee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose of polyphenols from soluble coffee</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose green tea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose of green tea polyphenols from infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium dose green tea infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medium dose of green polyphenols from infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose green tea infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low dose of polyphenols from an infusion of green tea</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Green tea</intervention_name>
    <description>Infusion (tea bags) from commercially available green tea</description>
    <arm_group_label>High dose green tea</arm_group_label>
    <arm_group_label>Medium dose green tea infusion</arm_group_label>
    <arm_group_label>Low dose green tea infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coffee</intervention_name>
    <description>Soluble coffee commercially available</description>
    <arm_group_label>High dose coffee</arm_group_label>
    <arm_group_label>Medium dose coffee</arm_group_label>
    <arm_group_label>Low dose coffee</arm_group_label>
    <other_name>Soluble coffee</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 - 65 years, male and female

          -  Healthy as determined by the medical questionnaire and the medical visit

          -  Normal weight: BMI 18 - 25

          -  Coffee drinkers with an average consumption of 2-5 cups per day

          -  Having given informed consent

        Exclusion Criteria:

          -  Intestinal or metabolic diseases / disorders such as diabetic, renal, hepatic,
             hypertension, pancreatic or ulcer

          -  Have had a gastrointestinal surgery, except appendicectomy

          -  Difficulty to swallow

          -  Have a regular consumption of medication

          -  Have taken antibiotic therapy within the last 6 months

          -  Alcohol consumption &gt; 2 units a day

          -  Smokers (more than 5 cigarettes per day)

          -  Have given blood within the last 3 weeks

          -  Volunteers who cannot be expected to comply with treatment

          -  Currently participating or having participated in another clinical trial during the
             last 3 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurice Beaumont, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nestec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nestle Research Center</name>
      <address>
        <city>Lausanne</city>
        <zip>1000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2010</study_first_submitted>
  <study_first_submitted_qc>March 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2010</study_first_posted>
  <last_update_submitted>June 4, 2014</last_update_submitted>
  <last_update_submitted_qc>June 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

